Exploratory Biomarker Analysis of PD-1/CTLA-4 Bispecific Antibody Therapy Response in PD-L1-Negative Advanced Non-Small Cell Lung Cancer: Genomic and Transcriptomic Profiling from the Phase II LungCadX StudyWang Li, Chunxia Su, Qi Wang et al.|SSRN Electronic Journal|2025Cited by 0